LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 17.28 | 27.76 | 976 | 838 | 1.1637 | 1.0626 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.98 | 27.76 | 13 | 941 | 0.0138 | -0.1386 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.98 | 27.76 | 999 | 941 | 1.0615 | 1.0236 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.98 | 27.76 | 1 | 941 | 0.0011 | -0.4799 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.98 | 27.76 | 997 | 941 | 1.0594 | 1.0228 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.68 | 27.76 | 11 | 1119 | 0.0098 | -0.1593 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.68 | 27.76 | 1013 | 1119 | 0.9053 | 0.9630 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.68 | 27.76 | 2 | 1119 | 0.0018 | -0.3893 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.68 | 27.76 | 1029 | 1119 | 0.9196 | 0.9688 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.39 | 27.76 | 17 | 1305 | 0.0130 | -0.0845 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.39 | 27.76 | 1067 | 1305 | 0.8172 | 0.9286 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.39 | 27.76 | 7 | 1305 | 0.0054 | -0.2196 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.39 | 27.76 | 1108 | 1305 | 0.8486 | 0.9418 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.09 | 27.76 | 20 | 1461 | 0.0137 | -0.0557 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.09 | 27.76 | 1110 | 1461 | 0.7594 | 0.9060 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.09 | 27.76 | 12 | 1461 | 0.0082 | -0.1364 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.09 | 27.76 | 1152 | 1461 | 0.7882 | 0.9185 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 25.79 | 27.76 | 25 | 1605 | 0.0156 | -0.0177 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 25.79 | 27.76 | 1128 | 1605 | 0.7027 | 0.8830 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 25.79 | 27.76 | 14 | 1605 | 0.0087 | -0.1104 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 25.79 | 27.76 | 1204 | 1605 | 0.7501 | 0.9041 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 27.49 | 27.76 | 27 | 1723 | 0.0157 | -0.0046 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 27.49 | 27.76 | 1195 | 1723 | 0.6935 | 0.8808 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 27.49 | 27.76 | 16 | 1723 | 0.0093 | -0.0884 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 27.49 | 27.76 | 1225 | 1723 | 0.7109 | 0.8886 | MN20160318_Q01 | G15 |